Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 14, Issue 9, Pages 17958-17971
Publisher
MDPI AG
Online
2013-09-04
DOI
10.3390/ijms140917958
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
- (2013) Matija Snuderl et al. CELL
- Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
- (2013) Gaurav Sahay et al. NATURE BIOTECHNOLOGY
- PlGF: A Multitasking Cytokine with Disease-Restricted Activity
- (2013) M. Dewerchin et al. Cold Spring Harbor Perspectives in Medicine
- A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours
- (2012) U Lassen et al. BRITISH JOURNAL OF CANCER
- Castration-resistant metastatic prostate cancer: current status and treatment possibilities
- (2012) Joan Carles et al. Clinical & Translational Oncology
- The reactive stroma microenvironment and prostate cancer progression
- (2012) David A Barron et al. ENDOCRINE-RELATED CANCER
- The discovery of placenta growth factor and its biological activity
- (2012) Sandro De Falco EXPERIMENTAL AND MOLECULAR MEDICINE
- Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts
- (2012) Huang-Ju Tu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inhibition of TGF-β/Smad Signaling by BAMBI Blocks Differentiation of Human Mesenchymal Stem Cells to Carcinoma-Associated Fibroblasts and Abolishes their Protumor Effects
- (2012) Lei Shangguan et al. STEM CELLS
- Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia
- (2011) Thomas Schmidt et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic Therapy
- (2011) R. G. Bagley et al. CLINICAL CANCER RESEARCH
- Monoclonal Antibody TB-403: A First-in-Human, Phase I, Double-Blind, Dose Escalation Study Directed Against Placental Growth Factor in Healthy Male Subjects
- (2011) Titti Martinsson-Niskanen et al. CLINICAL THERAPEUTICS
- New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety
- (2011) Himisha Beltran et al. EUROPEAN UROLOGY
- Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer
- (2011) Vincenzo Pagliarulo et al. EUROPEAN UROLOGY
- Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy
- (2011) J. Yao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reversible Ponceau staining as a loading control alternative to actin in Western blots
- (2010) Isabel Romero-Calvo et al. ANALYTICAL BIOCHEMISTRY
- PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
- (2010) Carlos Bais et al. CELL
- VEGFR1-activity-independent metastasis formation
- (2009) Michelle R. Dawson et al. NATURE
- VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis
- (2008) Takaaki Fujii et al. ATHEROSCLEROSIS
- Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts
- (2008) Dietmar Abraham Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started